BIOQUÍMICA Y BIOLOGÍA MOLECULAR III E INMUNOLOGÍA
Departamento
German Cancer Research Center
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de German Cancer Research Center (11)
2023
-
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339
2022
-
Autophagy in Hematological Malignancies
Cancers, Vol. 14, Núm. 20
-
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study
Blood Cancer Journal
2021
2020
-
Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium
Blood Cancer Journal, Vol. 10, Núm. 7
2016
-
Redefining cancer immunotherapy—optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27–30, 2015, Ljubljana, Slovenia
Cancer Immunology, Immunotherapy, Vol. 65, Núm. 7, pp. 875-883
-
The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells
Oncotarget, Vol. 7, Núm. 16, pp. 21875-21886
2012
-
Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): Moving forward
Journal of Immunotoxicology, Vol. 9, Núm. 3, pp. 231-235
-
From cell regulation to patient survival: 2nd Cancer immunotherapy and immunomonitoring (CITIM) meeting, Budapest, 2-5 May 2011
Cancer Immunology, Immunotherapy
2009
-
Efficient recovery of HLA class i expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: Implications for cancer immunotherapy
Scandinavian Journal of Immunology, Vol. 70, Núm. 2, pp. 125-135
1980
-
Foreign H-2-like molecules on a murine tumor (MCG4): Target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL
Transplantation Proceedings, Vol. 12, Núm. 1, pp. 32-37